This Report covers the key technological and market trends in the Injectable Drug Delivery market and further lays out an analysis of the factors influencing the supply/demand for Injectable Drug Delivery, and the opportunities/challenges faced by industry participants.
Global Injectable Drug Delivery Market Report 2018 provides a comprehensive analysis and industry insights from experts. The Global Injectable Drug Delivery market is accounted for $348.64 billion in 2015 and is expected to reach $866.31 billion by 2022 growing at a CAGR of 13.9%.
Rising incidences of chronic diseases, technological advancements and increase in demand for self-injection devices are some of the factors proliferating market demand. However, factors such as needle-stick injuries and lack of access to or failure to use appropriate personal protective equipment are some factors inhibiting the market.
The report analysis is based on a systematic and detailed segmentation of the Global Injectable Drug Delivery market. Furthermore, the Injectable Drug Delivery report also covers the sub-segments, if applicable.
The report includes details such as region-wise leading Injectable Drug Delivery markets and the emerging markets, along with Injectable Drug Delivery market growth statistics in terms of revenue during the forecast period. It aims to fulfill the needs of the clients looking for a fresh outlook towards the Global Injectable Drug Delivery Market, or fill in the knowledge gaps with the data available in the report.
The well-presented and curated report is compiled by seasoned and professional research experts and subject matter experts in the field. The clients will find the report complete in all aspects as it covers all key components with valuable statistics and expert opinions in all regards.
Oncology and Hormonal disorder segment among therapeutic applications is expected to dominate the market owing to the rising number of patients suffering from diabetes and oncologic disorders. Moreover, self-injection device segment in product type is estimated to be the fastest growing segment on account of growing geriatric people coupled with diabetic patients.
North American market is estimated to be the dominant among others attributed to its huge patient base and healthcare sector. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector.
Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, ELI Lilly and Company, Gerresheimer AG, Novo Nordisk, Pfizer, Inc., Sandoz, Schott AG, Terumo Corporation and Teva Pharmaceutical Industries Ltd.
Therapeutic Applications Covered:
- • Autoimmune Diseases
o Crohn’s Disease
o Multiple Sclerosis
o Rheumatoid Arthritis
o Other Autoimmune Diseases
- • Hormonal Disorders
o Antithrombotic/Thrombolytic Therapy
o Growth Hormone Deficiency (GHD)
o Reproductive Health Disease
- • Orphan Diseases
- • Oncology
- • Other Therapeutic Applications
o Pain Management
o Allergy Treatment
o Aesthetic Treatments
o Hepatitis C
- • Home Care Settings
- • Hospitals and Clinics
- • Pharmaceutical and Biotechnology Companies
- • Research Laboratories
- • Other End Users
- • Auto-injectors
o Reusable Auto-injectors
o Disposable Auto-injectors
o Product Specific Auto-injectors
- • Pen Injectors
o Custom Pen Designs
o Disposable Pens
o Dual Chamber Pens
o Prefilled Pen Cartridges
o Standardized Pen Platforms
- • Needle-free Injectors
Category: Market Research Publishers and RetailersCompany about: Report Hive Research delivers strategic market research reports, statistical survey, and industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, ...